TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RNTX

Rein Therapeutics Inc

Healthcare · Biotechnology

0.7892$ +12.4% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Rein Therapeutics Inc (RNTX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/13/2026.

Next report 08/13/2026
Last report 08/14/2026
Earnings surprise by quarter (%)
Q3 23 · -100.0 % 23 Q4 23 · -862.5 % 23 Q1 24 · 15.7 % 24 Q2 24 · -7.1 % 24 Q3 24 · 22.9 % 24 Q4 24 · 45.6 % 24 Q1 25 · -19.1 % 25 Q2 25 · -27.3 % 25 Q3 25 · 12.5 % 25 Q4 25 · -467.4 % 25 Q1 26 · 61.2 % 26 Q2 26 · 63.0 % 26

EPS estimate beaten

Full history 15 of 34 quarters (44%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/04/2026 Rein Therapeutics, Inc. (RNTX): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/27/2026 Rein Therapeutics, Inc. (RNTX): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗
  • 07/21/2026 Rein Therapeutics, Inc. (RNTX): Submission of Matters to a Vote of Security Holders · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?